Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer

European Journal of Medical Research

Volumn 14, Issue 11, 2009, Pages 487-490

  Karl, Alexander ^a   Tritschler, S ^a   Hofmann, S ^b   Stief, C G ^a   Schindlbeck, C ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bladder cancer; Cell search system; Circulating tumor cells; CTC; Perioperative tumor cell detection

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD VOLUME; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LYMPH NODE DISSECTION; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; PERIOPERATIVE PERIOD; TRANSITIONAL CELL CARCINOMA; TUMOR CELL;

EID: 72249084729     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-11-487     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249
2. Vaidya A, Soloway MS, Hawke C, et al. De novo muscle invasive bladder cancer: is there a change in trend? J Urol. 2001;165(1):47-50.
3. Prout GR, Jr., Griffin PP, Shipley WU. Bladder carcinoma as a systemic disease. Cancer. 1979;43(6):2532-2539
4. Karl A, Carroll PR, Gschwend JE, et al. The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer. Eur Urol. 2009;55(4):826-835
5. Messing EM CW. Urothelial tumors of the urinarytract. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds). New York, WB Saunders;1997: pp2327-2410.
6. Schindlbeck C, Stellwagen J, Jeschke U, et al. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin Exp Metastasis. 2008; 25(3): 233-240
7. Shelley MD, Barber J, Wilt T, et al. Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane. Database. Syst. Rev. 2002;(1)CD002079.
8. Bassi P, Ferrante GD, Piazza N, et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol. 1999;161(5):1494-1497 (Pubitemid 29420803)
9. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol. 2001; 165(4): 1111-1116 (Pubitemid 32210214)
10. Ghoneim MA, el-Mekresh MM, el-Baz MA, et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol. 1997;158(2):393-99.
11. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666-675 (Pubitemid 32120143)
12. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann.Oncol. 2000;11(7)851-856 (Pubitemid 30687897)
13. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781-791 (Pubitemid 39095313)
14. Sastre J, Maestro ML, Puente J, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol. 2008;19(5):935-938 (Pubitemid 351627310)
15. Shaffer DR, Leversha MA, Danila DC, et al. Circulating tumor cell analysis in patients with progressive castrationresistant prostate cancer. Clin Cancer Res. 2007;13(7):2023-2029 (Pubitemid 46649868)
16. Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res. 2006;12(21):6403-6409 (Pubitemid 44799711)
17. Danila DC, Heller G, Gignac GA, et al. Circulating tumor cell number and prognosis in progressive castrationresistant prostate cancer. Clin Cancer Res. 2007;13(23):7053-7058 (Pubitemid 350276887)
18. Moreno J DJSD. Multi-center study evaluating circulatingtumor cells (CTCs) as a surrogate for survival in men treated for castrationrefractory prostate cancer (CRPC). J Clin Oncol. 2007; 25: 5016.
19. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10(20):6897-6904. (Pubitemid 39383039)
20. Naoe M, Ogawa Y, Morita J, et al. Detection of circulating urothelial cancer cells in the blood using the Cell Search System. Cancer. 2007;109(7):1439-1445 (Pubitemid 46466573)
21. Gallagher DJ, Milowsky MI, Ishill N, et al. Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol. 2009;20(2):305-308